Atrilesto 97 mg/103 mg filmom obložene tablete
| Name | Atrilesto 97 mg/103 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-598843196 |
| Active Substance | sakubitrilnatrij valsartandinatrij |
| Composition | jedna filmom obložena tableta sadrži sakubitrilnatrij, što odgovara 97,2 mg sakubitrila i valsartannatrij, što odgovara 102,8 mg valsartana |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Elpen Pharmaceutical Co.Inc. (SA), Keratea, Grčka Elpen Pharmaceutical Co.Inc. (SA), Pikermi, Attica, Grčka Pharmacare Premium Ltd., Birzebbugia, Malta |
| Marketing Authorisation Holder | TEVA GmbH, Graf-Arco-Strasse 3, Ulm, Njemačka |
| Marketing Authorisation Date | 11.07.2025 |
| MA Period of Validity | 11.07.2030 |
| Classification Number | UP/I-530-09/23-01/340 |
| Registration Number | 381-12-01/171-25-08 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09DX04 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |